The Vascularization Crisis in 3D Bioprinting: Channel Engineering, Anastomosis, and the Missing Bridge to In Vivo Perfusion

Ignatius Echezona Ekengwu ORCID ,  Damian Chigozie Anyadike ,  Anthonia Ekene Ilechukwu ,  Swift Onyegirim ORCID
    Received: 27 September 2025; Revised: 12 November 2025; Accepted: 16 November 2025; Published: 12 December 2025

    Abstract

    Fabricating living tissues thick enough to sustain organ-level function requires a functional vascular supply, as cells beyond approximately 200 µm from a nutrient source cannot maintain aerobic metabolism regardless of architectural refinement. This review examines the vascularization challenge in 3D bioprinting through the lens of engineering failure analysis, identifying the specific barriers preventing in vitro success from translating to in vivo function. Three interlocking challenges are systematically addressed: fabricating hierarchically organized channels spanning the full vascular tree from millimetre-scale trunks to sub-100 µm capillary beds; the range of anastomotic strategies researchers are pursuing to connect printed channels with host circulation; and the persistent, poorly explained failure of constructs that perform well in bioreactors to maintain perfusion after implantation. Drawing on mechanistic evidence from materials science, vascular biology, and surgical literature, four root causes of in vivo failure are identified: stiffness mismatch between printed and native vessel walls; temporal mismatch between hydrogel degradation and angiogenic invasion; the near-universal omission of pericyte support from bioprinted endothelial networks; and immunological assault on allogeneic endothelial linings inadequately shielded by current bioinks. None of these failure modes is inevitable, yet none will be resolved through printing technology alone. Progress requires simultaneous advances in bioink mechanobiology, co-culture vascular biology, bioreactor conditioning, and shared performance benchmarks that the field currently lacks. A structured three-phase translational roadmap organized around objectively measurable milestones is proposed to focus research effort on the specific barriers that current evidence identifies as rate-limiting.

    Keywords

    References

    1. 1. Langer, R.; Vacanti, J.P. Tissue engineering. Science 1993, 260, 920–926.
    2. 2. Atala, A.; Bauer, S.B.; Soker, S.; et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367, 1241–1246.
    3. 3. Sun, X.; Ren, W.; Xie, L.; et al. Recent advances in 3D bioprinting of tissues and organs for transplantation and drug screening. Virtual Phys. Prototyp. 2024, 19, e2384662.
    4. 4. Khademhosseini, A.; Langer, R. A decade of progress in tissue engineering. Nat. Protoc. 2016, 11, 1775–1781.
    5. 5. Gao, G.; Cui, X. Three-dimensional bioprinting in tissue engineering and regenerative medicine. Biotechnol. Lett. 2016, 38, 203–211.
    6. 6. Saunders, R.E.; Derby, B. Inkjet printing biomaterials for tissue engineering: bioprinting. Int. Mater. Rev. 2014, 59, 430–448.
    7. 7. Guillotin, B.; Souquet, A.; Catros, S.; et al. Laser-assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials 2010, 31, 7250–7256.
    8. 8. Zhang, Y.S.; Arneri, A.; Bersini, S.; et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 2016, 110, 45–59.
    9. 9. Liu, N.; Ye, X.; Yao, B.; et al. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration. Bioact. Mater. 2021, 6, 1388–1401.
    10. 10. Skylar-Scott, M.A.; Uzel, S.G.M.; Nam, L.L.; et al. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels. Sci. Adv. 2019, 5, eaaw2459.
    11. 11. Kolesky, D.B.; Homan, K.A.; Skylar-Scott, M.A.; et al. Three-dimensional bioprinting of thick vascularized tissues. Proc. Natl. Acad. Sci. U.S.A. 2016, 113, 3179–3184.
    12. 12. Homan, K.A.; Kolesky, D.B.; Skylar-Scott, M.A.; et al. Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci. Rep. 2016, 6, 34845.
    13. 13. Mannoor, M.S.; Jiang, Z.; James, T.; et al. 3D printed bionic ears. Nano Lett. 2013, 13, 2634–2639.
    14. 14. Shen, M.; Wang, L.; Gao, Y.; et al. 3D bioprinting of in situ vascularized tissue engineered bone for repairing large segmental bone defects. Mater. Today Bio 2022, 16, 100382.
    15. 15. Lee, A.; Hudson, A.R.; Shiwarski, D.J.; et al. 3D bioprinting of collagen to rebuild components of the human heart. Science 2019, 365, 482–487.
    16. 16. Mazloomnejad, R.; Babajani, A.; Kasravi, M.; et al. Angiogenesis and re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering. Front. Bioeng. Biotechnol. 2023, 11, 1103727.
    17. 17. Akbari, M.; Khademhosseini, A. Tissue bioprinting for biology and medicine. Cell 2022, 185, 2644–2648.
    18. 18. Moroni, L.; Boland, T.; Burdick, J.A.; et al. Biofabrication: A guide to technology and terminology. Trends Biotechnol. 2018, 36, 384–402.
    19. 19. Yeo, M.; Sarkar, A.; Singh, Y.P.; et al. Synergistic coupling between 3D bioprinting and vascularization strategies. Biofabrication 2024, 16, 012003.
    20. 20. Samandari, M.; Mostafavi, A.; Quint, J.; et al. In situ bioprinting: Intraoperative implementation of regenerative medicine. Trends Biotechnol. 2022, 40, 1229–1247.
    21. 21. Datta, P.; Ayan, B.; Ozbolat, I.T. Bioprinting for vascular and vascularized tissue biofabrication. Acta Biomater. 2017, 51, 1–20.
    22. 22. Rouwkema, J.; Khademhosseini, A. Vascularization and angiogenesis in tissue engineering: beyond creating static networks. Trends Biotechnol. 2016, 34, 733–745.
    23. 23. Liu, J.; Song, Q.; Yin, W.; et al. Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations. Exploration 2024, 4, 20230078.
    24. 24. Grigoryan, B.; Paulsen, S.J.; Corbett, D.C.; et al. Multivascular networks and functional intravascular topologies within biocompatible hydrogels. Science 2019, 364, 458–464.
    25. 25. Taylor, C.A.; Draney, M.T. Experimental and computational methods in cardiovascular fluid mechanics. Annu. Rev. Fluid Mech. 2004, 36, 197–231.
    26. 26. Galie, P.A.; Nguyen, D.H.; Choi, C.K.; et al. Fluid shear stress threshold regulates angiogenic sprouting. Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 7968–7973.
    27. 27. Tocchio, A.; Tamplenizza, M.; Martello, F.; et al. Versatile fabrication of vascularizable scaffolds for large tissue engineering in bioreactor. Biomaterials 2015, 45, 124–131.
    28. 28. Wang, H.; Liu, X.; Gu, Q.; et al. Vascularized organ bioprinting: From strategy to paradigm. Cell Prolif. 2023, 56, e13453.
    29. 29. Kim, J.J.; Cho, D.W. Advanced strategies in 3D bioprinting for vascular tissue engineering and disease modelling using smart bioinks. Virtual Phys. Prototyp. 2024, 19, e2395470.
    30. 30. Lee, S.J.; Jeong, W.; Atala, A. 3D bioprinting for engineered tissue constructs and patient-specific models: Current progress and prospects in clinical applications. Adv. Mater. 2024, 36, e2408032.
    31. 31. Gao, Q.; He, Y.; Fu, J.Z.; et al. Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. Biomaterials 2015, 61, 203–215.
    32. 32. Jia, W.; Gungor-Ozkerim, P.S.; Zhang, Y.S.; et al. Direct 3D bioprinting of perfusable vascular constructs using a blend bioink. Biomaterials 2016, 106, 58–68.
    33. 33. Shao, L.; Gao, Q.; Xie, C.; et al. Directly coaxial 3D bioprinting of large-scale vascularized constructs with complex geometry. Biofabrication 2020, 12, 035014.
    34. 34. Miller, J.S.; Stevens, K.R.; Yang, M.T.; et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 2012, 11, 768–774.
    35. 35. Kolesky, D.B.; Truby, R.L.; Gladman, A.S.; et al. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv. Mater. 2014, 26, 3124–3130.
    36. 36. Zhu, W.; Qu, X.; Zhu, J.; et al. Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture. Biomaterials 2017, 124, 106–115.
    37. 37. Hinton, T.J.; Jallerat, Q.; Palchesko, R.N.; et al. Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels. Sci. Adv. 2015, 1, e1500758.
    38. 38. Ouyang, L.; Highley, C.B.; Sun, W.; et al. A generalizable strategy for the 3D bioprinting of hydrogels from nonviscous photo-crosslinkable inks. Adv. Mater. 2017, 29, 1604983.
    39. 39. Brassard, J.A.; Nikolaev, M.; Hübscher, T.; et al. Recapitulating macro-scale tissue self-organization through organoid bioprinting. Nat. Mater. 2021, 20, 22–29.
    40. 40. Skylar-Scott, M.A.; Huang, J.Y.; Lu, A.; et al. Orthogonally induced differentiation of stem cells for the programmatic patterning of vascularized organoids and bioprinted tissues. Nat. Biomed. Eng. 2022, 6, 449–462.
    41. 41. Levenberg, S.; Rouwkema, J.; Macdonald, M.; et al. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 2005, 23, 879–884.
    42. 42. Laschke, M.W.; Harder, Y.; Amon, M.; et al. Angiogenesis in tissue engineering: Breathing life into constructed tissue substitutes. Tissue Eng. 2006, 12, 2093–2104.
    43. 43. Sakaguchi, K.; Shimizu, T.; Horaguchi, S.; et al. In vitro engineering of vascularized tissue surrogates. Sci. Rep. 2013, 3, 1316.
    44. 44. Nguyen, D.H.; Stapleton, S.C.; Yang, M.T.; et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 6712–6717.
    45. 45. Laschke, M.W.; Menger, M.D. Vascularization in tissue engineering: Angiogenesis versus inosculation. Eur. Surg. Res. 2012, 48, 85–92.
    46. 46. Tremblay, P.L.; Hudon, V.; Berthod, F.; et al. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am. J. Transplant. 2005, 5, 1002–1010.
    47. 47. Hudon, V.; Berthod, F.; Black, A.F.; et al. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br. J. Dermatol. 2003, 148, 1094–1104.
    48. 48. Weigand, A.; Horch, R.E.; Boos, A.M.; et al. The arteriovenous loop: Engineering of axially vascularized tissue. Eur. Surg. Res. 2018, 59, 286–299.
    49. 49. Jiang, H.; Li, X.; Chen, T.; et al. Bioprinted vascular tissue: Assessing functions from cellular, tissue to organ levels. Mater. Today Bio 2023, 23, 100846.
    50. 50. Niklason, L.E.; Gao, J.; Abbott, W.M.; et al. Functional arteries grown in vitro. Science 1999, 284, 489–493.
    51. 51. Furdella, K.J.; Higuchi, S.; Behrangzade, A.; et al. In-vivo assessment of a tissue engineered vascular graft computationally optimized for target vessel compliance. Acta Biomater. 2021, 123, 298–311.
    52. 52. Murfee, W.L.; Wagenseil, J.E. Editorial: Putting engineering back in vascular tissue engineering to advance basic science and clinical applications. Front. Cardiovasc. Med. 2022, 9, 1025465.
    53. 53. Shakeel, A.; Corridon, P.R. Mitigating challenges and expanding the future of vascular tissue engineering—are we there yet? Front. Physiol. 2023, 14, 1079421.
    54. 54. Kyriakides, T.R.; Kim, H.J.; Zheng, C.; et al. Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity. Biomed. Mater. 2022, 17, 022007.
    55. 55. Ricklin, D.; Hajishengallis, G.; Yang, K.; et al. Complement: A key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11, 785–797.
    56. 56. Anderson, J.M.; Rodriguez, A.; Chang, D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20, 86–100.
    57. 57. Hachim, D.; LoPresti, S.T.; Yates, C.C.; et al. Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration. Biomaterials 2017, 112, 95–107.
    58. 58. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663–676.
    59. 59. Bhattacharjee, T.; Zehnder, S.M.; Rowe, K.G.; et al. Writing in the granular gel medium. Sci. Adv. 2015, 1, e1500655.
    60. 60. Baranski, J.D.; Chaturvedi, R.R.; Stevens, K.R.; et al. Geometric control of vascular networks to enhance engineered tissue integration and function. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 7586–7591.
    61. 61. Shin, J.; Lee, Y.; Li, Z.; et al. Optimized 3D bioprinting technology based on machine learning: A review of recent trends and advances. Micromachines 2022, 13, 363.
    62. 62. Bersini, S.; Gilardi, M.; Arrigoni, C.; et al. Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach. Biomaterials 2016, 76, 157–172.
    63. 63. Loterie, D.; Delrot, P.; Moser, C. High-resolution tomographic volumetric additive manufacturing. Nat. Commun. 2020, 11, 852.
    64. 64. Bernal, P.N.; Delrot, P.; Loterie, D.; et al. Volumetric bioprinting of complex living-tissue constructs within seconds. Adv. Mater. 2019, 31, e1904209.
    65. 65. Ghorbanian, S.; Qasaimeh, M.A.; Akbari, M.; et al. Microfluidic direct writer with integrated declogging mechanism for fabricating cell-laden hydrogel constructs. Biomed. Microdevices 2014, 16, 387–395.
    66. 66. Colosi, C.; Shin, S.R.; Manoharan, V.; et al. Microfluidic bioprinting of heterogeneous 3D tissue constructs using low-viscosity bioink. Adv. Mater. 2016, 28, 677–684.
    67. 67. Jentsch, S.; Nasehi, R.; Kuckelkorn, C.; et al. Multiscale 3D bioprinting by nozzle-free acoustic droplet ejection. Small Methods 2021, 5, e2000971.
    68. 68. Souza, G.R.; Molina, J.R.; Raphael, R.M.; et al. Three-dimensional tissue culture based on magnetic cell levitation. Nat. Nanotechnol. 2010, 5, 291–296.
    69. 69. Krebs, M.D.; Erb, R.M.; Yellen, B.B.; et al. Formation of ordered cellular structures in suspension via label-free negative magnetophoresis. Nano Lett. 2009, 9, 1812–1817.
    70. 70. Hague, J.P. Simultaneous self-organization of arterial and venous networks driven by the physics of global power optimization. arXiv preprint 2023, arXiv.2308.02700. DOI: https://doi.org/10.48550/arXiv.2308.02700
    71. 71. Alitalo, K. The lymphatic vasculature in disease. Nat. Med. 2011, 17, 1371–1380.
    72. 72. Kolarzyk, A.M.; Wong, G.; Lee, E. Lymphatic tissue and organ engineering for in vitro modeling and in vivo regeneration. Cold Spring Harb. Perspect. Med. 2022, 12, a041169.
    ×